Report Categories
View AllRecent Articles
View All
System1 SST Stock Downside Risk Evaluation Edges Lower 20260418
What would it take for Argo Blockchain ARBK to double from here 283 20260508
ACDC ProFrac Holding Corp falls 451 after its Q4 2025 EPS misses analyst estimates by 163 percent
Is The GRX stock under speculative pressure Overhead Buying 20260420
Werewolf Therapeutics HOWL Stock Bid Wall Smart Money Exits 20260420
nCino NCNO Stock Stop Limit Order Smart Money Flows 20260420
ADBE Adobe Q1 2026 results top EPS estimates 105 percent year over year revenue growth lifts shares 163 percent
UK Political Uncertainty Intensifies as Labour Leadership Questions Mount
Chinas Ongoing CatandMouse Game to Rein In Crypto Trading
ixigo Partners with Uber and redBus to Integrate Cab and Bus Bookings for Train Travellers
Beeline Holdings CEO Nicholas Liuzza Acquires 53586 in BLNE Shares
Xilio Therapeutics XLO Crushes Q1 2026 Estimates EPS 058 Tops Views
Huadi HUDI Gains 862 Support Holds at 120 20260515
Kazatomprom Reports 17 Production Increase in Third Quarter
Saudi Arabias Vision 2030 Spending Spree Faces Fiscal Reality Check
Beyond Alpha Four LowRisk Strategies for Consistent Market Gains
Skymap Pharma Emerges as Highest Bidder for IMPCL as Centre Advances Disinvestment
Mortgage Rates Decline Across the Board on May 23 2026 30Year Fixed Drops to 634
US Pauses Arms Sales to Taiwan Amid Iran Conflict Acting Navy Chief Indicates
FGBI Q1 2026 Earnings EPS Surges 96 Above Estimates Stock Declines Despite Strong Performance
SPWH Q1 2026 Earnings Narrow EPS Miss Amid Unreported Revenue Weighs on Sentiment
BMBL Q1 2026 Earnings EPS Surges Past Estimates with 224 Beat
RXT Q1 2026 Earnings EPS Misses Estimates by a Wide Margin Shares Decline
KULR Q3 2025 Earnings Massive EPS Miss Highlights Ongoing Challenges
ESLA Q1 2026 Earnings WiderThanExpected Loss and No Revenue Highlight DevelopmentStage Challenges
Spring Valley Acquisition Corp IV Units SVIVU Hold Steady at 1026 Amid Quiet Trading
Service Properties Trust SVC Gains 286 as Shares Test Resistance Near 189
Cellectis CLLS Stock Dips 127 as Biotech Volatility Persists Key Support at 332 in Focus
Equinix EQIX Edges Higher as Stock Consolidates Between Key Support and Resistance Levels
Twist Bioscience TWST Holds Steady Near Midpoint as Key Levels Define Trading Range